![Pharmaceutical sciences / Pharmacology / Business / Pharmaceutical industry / Pharmacy / Biotechnology / European Federation of Pharmaceutical Industries and Associations / Immunogenicity / Drug discovery / Novartis / Biopharmaceutical / Sanofi Pharmaceutical sciences / Pharmacology / Business / Pharmaceutical industry / Pharmacy / Biotechnology / European Federation of Pharmaceutical Industries and Associations / Immunogenicity / Drug discovery / Novartis / Biopharmaceutical / Sanofi](https://www.pdfsearch.io/img/266406551e2ef09f022ec8c760525aad.jpg) Date: 2012-06-04 10:07:55Pharmaceutical sciences Pharmacology Business Pharmaceutical industry Pharmacy Biotechnology European Federation of Pharmaceutical Industries and Associations Immunogenicity Drug discovery Novartis Biopharmaceutical Sanofi | | ABIRISK ABIRISK Project Officially Started A growing number of medicines are based on biological molecules such as proteins and monoclonal antibodies. These novel drugs have resulted in new, more effective treatments forAdd to Reading ListSource URL: www.abirisk.euDownload Document from Source Website File Size: 117,56 KBShare Document on Facebook
|